Journal of Cystic Fibrosis

60 papers1 directions
The Journal of Cystic Fibrosis is a specialized publication focusing on the clinical, social, and basic science aspects of cystic fibrosis. Active from 2005 to 2025, the venue serves as a repository for research concerning airway infections, epidemiological trends, and the efficacy of therapeutic interventions. Its corpus includes studies on the evolution of transcriptional regulators in pathogens such as M. abscessus and the longitudinal impact of infection prevention and control guidelines. In the context of machine learning and data science, the journal provides a platform for applying computational models to complex biological and clinical datasets. Research published here often utilizes data-driven approaches to analyze within-host evolution, selection scans for genetic drivers of bacterial survival, and the development of non-invasive diagnostic technologies such as resonant acoustic rheometry. These studies bridge the gap between technical methodology and practical applications in chronic disease management, particularly regarding the analysis of treatment-emergent organisms and the outcomes of modulator therapies. The venue features contributions from prolific researchers in the field, including Jochen G. Mainz, Marianne S. Muhlebach, and B. Wiedemann. By hosting investigations into the association between antibiotic use and pathogenic adaptation, the journal facilitates the integration of quantitative analysis into cystic fibrosis care. It functions as a specialized venue for researchers applying analytical tools to improve patient monitoring, diagnostic accuracy, and long-term therapeutic strategies.

Papers by Year

2025 11
2024 6
2023 4
2022 1
2021 5
2020 1
2018 2
2017 5
2016 2
2015 1
2014 5
2013 4
2012 2
2011 2
2010 3
2009 3
2008 1
2006 1
2005 1

Top Research Directions

Research directions most represented by papers from this venue.

Indirect and Multifactorial Drivers of Muscle Weakness 1

Top Authors

AuthorPapers
Brice Hoffmann5
Qiongshi Lu3
Oliver Biggs Clarke2
Christian Gagné1
Dessi P. Zaharieva1
Dick B.M. Botteldooren1
Hamid Alinejad-Rokny1
Irina Lehmann1
Karla DiazOrdaz1
Mikhail Tamm1
N. Jon Shah1
Roland Eils1

Impactful Papers

Papers from this venue that shaped research clusters.

Foundational

Related Venues

Venues with the most similar research cluster distributions.

Papers

TitleYear
16 Artificial intelligence integrating gut microbiome multi-omics to predict clinical outcomes in children with cystic fibrosis2025
196 Development of a rapid, non-invasive in situ detection of in vitro mucus characteristics using resonant acoustic rheometry (RAR)2025
283 Hierarchical protein unfolding at the site of a functional conformational change in human CFTR is the Achilles’ Heel controlling biogenesis efficiency and corrector-drug mechanism2025
73 Epidemiology of Pseudomonas aeruginosa infection before and after the 2013 Infection Prevention and Control Guidelines2025
79 Selection scan reveals algG as a putative driver of Pseudomonas aeruginosa survival in the post-ETI lung2025
853 Establishing a satellite cystic fibrosis clinic: one center’s experience2025
89 Within-host evolution of transcriptional regulators drives pathogenic adaptation in M. abscessus2025
AI-facilitated home monitoring for cystic fibrosis exacerbations across pediatric and adult populations2025
Association between inhaled antibiotic use and treatment-emergent organisms among Canadian people with cystic fibrosis2025
P182 Physiotherapy discontinuation in adult patients on highly effective modulator therapy2025
P364 Emergent airway infections with chronic inhaled antibiotics2025
514 Real-word effectiveness of a Pseudomonas aeruginosa eradication protocol in children with cystic fibrosis2024
836 Aggregated genetic modifiers predict lung function in childrenwith CF aged 5 to 62024
Changes in factors associated with inhaled antibiotic prescriptions for people with cystic fibrosis over time in the U.S.2024
Vitamin D status and variable responses to supplements depend in part on genetic factors in adults with cystic fibrosis2024
WS05.03 Pharmacological improvement of CFTR function rescues airway epithelial homeostasis and host defense in children with cystic fibrosis2024
WS05.06 Integration of the LacZ and CFTR transgene using Find and cut-and-transfer (FiCAT)2024
335 Cryogenic electron microscopy studies of human CFTR folding and conformational dynamics elucidate a novel potentiator binding site in the nucleotide binding domains that supports an alternative ch2023
Association of Pseudomonas aeruginosa incident infections with adherence to cystic fibrosis foundation care guidelines2023
WS09.05 Aggregated genetic modifiers predict lung dysfunction at age 5–6 years in children with cystic fibrosis2023
WS10.04 Analyzes of worldwide inhaled antibiotic prescriptions for Pseudomonas aeruginosa2023
Predicting risk-adjusted incidence rates of methicillin-resistant Staphylococcus Aureus and Pseudomonas Aeruginosa in cystic fibrosis programs in the United States2022
568: Quantifying regional pulmonary ventilation changes pre-/postivacaftor treatment in same subject using hyperpolarized 3He MRI2021
Barriers implementing infection prevention and control experienced by healthcare workers, people with CF and parents2021
Longitudinal changes and regional variation of incident infection rates at cystic fibrosis centers, United States 2010-20162021
Pregnancy in cystic fibrosis: Review of the literature and expert recommendations2021
WS08.6 Impact of triple therapy on IVantibiotic requirements in cystic fibrosis: combining evidence from a patient Registry and randomised trials2021
WS17.1 Enhancing site-specific gene integration efficiency for permanent CFTR gene correction2020
P019 Advanced molecular dynamics simulations for understanding the functions and dysfunctions of the CFTR channel2018
P220 Pharmacist consultation introduced to annual review of adults with cystic fibrosis2018
25 Unsolved severe chronic rhinosinusitis elucidated by extensive CFTR genotyping2017
387 Exploring outpatient clinic attendance in adults with CF: what influences attendance?2017
Rare cases of Blastobotrys raffinosifermentans as cause of FEV1 decline in two CF patients – Whole genome sequencing to exclude transmission2017
Use of hyperpolarized helium-3 MRI to assess response to ivacaftor treatment in patients with cystic fibrosis2017
WS09.1 3D structures of the full length CFTR protein: combining theoretical and experimental data2017
82 The upper airway role in acquisition of Pseudomonas aeruginosa colonization in cystic fibrosis patients. Longitudinal single centre analysis following 153 CF patients for up to 10.6 years2016
Sino nasal inhalation of isotonic versus hypertonic saline (6.0%) in CF patients with chronic rhinosinusitis — Results of a multicenter, prospective, randomized, double-blind, controlled trial2016
146 Sinonasal inhalation of isotonic vs. hypertonic saline (6.0%) in CF patients with chronic rhinosinusitis – results of a multicentre, double-blind, controlled prospective trial2015
300 Pseudomonas aeruginosa colonization in a CF child's upper and lower airways: a father's meticulous approach to successful eradication2014
Disposition index identifies defective beta-cell function in cystic fibrosis subjects with normal glucose tolerance2014
Sinonasal inhalation of dornase alfa administered by vibrating aerosol to cystic fibrosis patients: A double-blind placebo-controlled cross-over trial2014
WS23.1 Models of the 3D structure of CFTR: from the understanding of the protein functions to the design of correctors2014
WS3.2 The effect of ivacaftor treatment on lung ventilation defects, as measured by hyperpolarized helium-3 MRI, on patients with cystic fibrosis and a G551D-CFTR mutation2014
178 Does nasal and bronchial nitric oxide in CF correlate to pathogen colonization in both airway levels?2013
183 Pseudomonas aeruginosa acquisition in CF patients in the context of otorhinolarynological surgery or dentist attendance – Case series and discussion of preventive concepts2013
Cost effectiveness of newborn screening for cystic fibrosis: A simulation study2013
WS4.1 New molecular models of CFTR based on ABC transporter structures2013
273 Smelling and tasting in CF patients compared to age matched healthy controls2012
Effect of acute exacerbations on skeletal muscle strength and physical activity in cystic fibrosis2012
83* Sinonasal inhalation of tobramycin in cystic fibrosis patients with P. aeruginosa colonization of the upper airways – results of a multicentric placebo-controlled pilot study2011

Page 1/2 next »